- Home
- CLRB vs EDUC Comparison
CLRB vs EDUC Comparison
Compare CLRB & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- EDUC
- Stock Information
- Founded
- CLRB 2002
- EDUC 1965
- Country
- CLRB United States
- EDUC United States
- Employees
- CLRB N/A
- EDUC N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- EDUC Consumer Specialties
- Sector
- CLRB Health Care
- EDUC Consumer Discretionary
- Exchange
- CLRB Nasdaq
- EDUC Nasdaq
- Market Cap
- CLRB 15.3M
- EDUC 14.6M
- IPO Year
- CLRB N/A
- EDUC N/A
- Fundamental
- Price
- CLRB $0.31
- EDUC $1.54
- Analyst Decision
- CLRB Buy
- EDUC
- Analyst Count
- CLRB 2
- EDUC 0
- Target Price
- CLRB $28.00
- EDUC N/A
- AVG Volume (30 Days)
- CLRB 1.4M
- EDUC 9.2K
- Earning Date
- CLRB 03-26-2025
- EDUC 01-13-2025
- Dividend Yield
- CLRB N/A
- EDUC N/A
- EPS Growth
- CLRB N/A
- EDUC N/A
- EPS
- CLRB N/A
- EDUC N/A
- Revenue
- CLRB N/A
- EDUC $36,523,200.00
- Revenue This Year
- CLRB N/A
- EDUC N/A
- Revenue Next Year
- CLRB N/A
- EDUC N/A
- P/E Ratio
- CLRB N/A
- EDUC N/A
- Revenue Growth
- CLRB N/A
- EDUC N/A
- 52 Week Low
- CLRB $0.22
- EDUC $1.46
- 52 Week High
- CLRB $4.45
- EDUC $2.95
- Technical
- Relative Strength Index (RSI)
- CLRB 46.10
- EDUC 41.93
- Support Level
- CLRB $0.26
- EDUC $1.51
- Resistance Level
- CLRB $0.35
- EDUC $1.67
- Average True Range (ATR)
- CLRB 0.03
- EDUC 0.08
- MACD
- CLRB 0.02
- EDUC -0.00
- Stochastic Oscillator
- CLRB 61.40
- EDUC 21.05
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.